Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Welcomes New Board Member

MIAMI — The National Parkinson Foundation (NPF) announced the election of a new member to its Board of Directors: Dr. Guido Goldman.

"We are flattered that Dr. Goldman has joined NPF’s Board," stated John W. Kozyak, Esq., NPF Chairman of the Board. "He knows firsthand how Parkinson’s affects the whole family—his father had Parkinson’s—and he is passionate about our mission to make life better for people living with this disease. Dr. Goldman has an international reputation and years of service which will greatly help the foundation.”

Guido Goldman, PhD, was elected to the board in May 2015. Dr. Guido Goldman has been the Director of the Program for the Study of Germany at the Minda de Gunzburg Center for European Studies of Harvard University since 1989. He served as Director of the Minda de Gunzburg Center for European Studies from 1969 to 1994. Dr. Goldman has been Chairman of the Board and President of First Spring Corporation, engaged in private asset management since 1985. Dr. Goldman served as Co-Chairman of German Marshall Fund of the United States, of which he was the founder. He serves as a Member of American Advisory Board at Christie's International SA. He also served as chairman of the American Foundation for Textile Art, Inc., and as a vice chairman of the board of the Alvin Ailey American Dance Theater, and a board member of the American Council on Germany. The Dr. Guido Goldman Fellowship for the Study of German and European Economic and International Affairs, sponsored by the American Council on Germany, was established in 2003 to honor Dr. Goldman’s work in political science and his study of economics and foreign relations as they apply to transatlantic affairs. 

View a complete list of the NPF Board of Directors.

About the National Parkinson Foundation (NPF)

Founded in 1957, the National Parkinson Foundation's mission is to make life better for people with Parkinson’s through expert care and research. NPF has funded more than $189 million in care, research and support services. For more information about NPF, visit www.parkinson.org, or call the NPF Helpline at 1-800-4PD-INFO (473-4636).

About Parkinson's Disease (PD)

Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety A feeling of nervousness, worried thoughts and physical distress.). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Friday, August 21, 2015
Parkinson’s Foundation Moving Day Walks Fund Local Parkinson’s Programs in Seven Cities for Spring 2018
Friday, February 16, 2018

NEW YORK & MIAMI, FEBRUARY 16, 2018 — The Parkinson’s Foundation is proud to announce that Moving Day, A Walk for Parkinson’s, has funded more than $17 million in mission services to make life better for people living with Parkinson’s disease (PD).

Terranova’s Stephen Bittel Donates $450,000 to Parkinson’s Foundation to Support Expansion of Centers of Excellence Network
Thursday, February 1, 2018

MIAMI – February 1, 2018 – The Parkinson’s Foundation today announced that Stephen Bittel, chairman and founder of Terranova, has made a $450,000 donation to support the expansion of the foundation’s Centers o

Largest Clinical Study of Parkinson’s Disease Reaches 10,000-Patient Milestone, Reveals Critical Learnings
Wednesday, January 10, 2018

NEW YORK & MIAMI - January 10, 2018 - The Parkinson’s Foundation today announced the enrollment of the 10,000th Parkinson’s patient and the discovery of critical new learnings in what represents the largest clinical study of Parkinson’s disease in history.

Parkinson's Foundation Mourns the Loss of Harold P. Kravitz and His Daughter, the Honorable Shelley J. Kravitz
Friday, January 5, 2018

Today we mourn the loss of two prominent figures in the history of the Parkinson's Foundation: Harold P. Kravitz, Esq. and his daughter, the Honorable Shelley J. Kravitz.

Parkinson's Foundation Mourns the Loss of Robert Burke, MD
Friday, January 5, 2018

The Parkinson’s Foundation mourns the loss of Robert Burke, MD, professor of Neurology at Columbia University, a Parkinson’s Foundation Center of Excellence. He was a former member of the Parkinson’s Disease Foundation (PDF) Scientific Advisory Board and led the PDF Research Center at Columbia.

Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.